Skip to main content

E

  • Chapter
  • 1391 Accesses

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   34.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Färkkilä M, Diener HC, Dahlöf C, Steiner TJ, on behalf of the Eletriptan Steering Committee (1996) A dose-finding study of eletriptan (5–30 mg) for the acute treatment of migraine. Cephalalgia 16:387

    Google Scholar 

  2. Goadsby PJ, Ferrari MD, Olesen J et al., for the Eletriptan Steering Committee (2000) Eletriptan in acute migraine: a double-blind, placebocontrolled comparison to sumatriptan. Neurology 54:156–163

    PubMed  CAS  Google Scholar 

  3. Pryse-Philips W, on behalf of the Eletriptan Steering Committee (1999) Comparison of oral eletriptan (Relpax™) (40–80 mg) and oral sumatriptan (50–100 mg) for the treatment of acute migraine. A randomised, placebo controlled study in sumatriptan-naive patients. In: 9th Congress of the International Headache Society

    Google Scholar 

  4. Reeches A, on behalf of the Eletriptan Steering Committee (1999) Comparison of the efficacy, safety and tolerability of oral eletriptan (Replax™) and Cafergot for the acute treatment of migraine. In: 9th Congress of the International Headache Society, Barcelona

    Google Scholar 

Literatur

  1. Gareth JP (1993). Guillain-Barré-Syndrome. Thieme Verlag Stuttgart-New York.

    Google Scholar 

Literatur

  1. Kleihues P, Cavenee WK (2000). Tumors of the Nervous System. WHO Classification of Tumors. IARC Press, Lyon.

    Google Scholar 

Literatur

  1. Brandt, Dichgans, Diener (1998). Therapie und Verlauf neurologischer Erkrankungen. Kohlhammer-Verlag, 3. Auflage, 461–463.

    Google Scholar 

Literatur

  1. Dale RC, De Sousa C, Chong WK et al. (2000) Acute disseminated encephalomyelitis, multiphasic encephalomyelitis and multiple sclerosis in children. Brain 123:2407–2422.

    Article  PubMed  Google Scholar 

  2. Haase CG, Faustmann PM, Diener H (1999). Idiopathic inflammatory demyelinating diseases of the central nervous system: differentiating between acute disseminated encephalomyelitis and malignant multiple sclerosis. J Clin Neurosci 6(3):221–226.

    Article  PubMed  Google Scholar 

  3. Littig E, Schmidt RM, Hoffmann F (2002). Differenzialdiagnose, Sonderformen und Diagnosesicherung der Multiplen Sklerose. In: Schmidt RM, Hoffmann F (Hrsg.) Multiple Sklerose. 3. Auflage. Urban & Fischer Verlag, München S.71–100.

    Google Scholar 

  4. McAlpine D (1931). Acute disseminated encephalomyelitis. Lancet 1: 846–852.

    Google Scholar 

  5. Poser S, Lüer W, Bruhn H, Frahm J, Brück Y, Felgenhauer K (1992). Acute demyelinating disease. Classification and non-invasive diagnosis. Acta Neurol Scand 86:579–585.

    PubMed  CAS  Google Scholar 

  6. Stoll G, Brück W (2001). Sonderformen der Multiplen Sklerose. In: Zettl UK, Mix E (Hrsg.) Multiple Sklerose — Kausalorientierte, symptomatische und rehabilitative Therapie. Springer-Verlag, Berlin New York, S.81–90.

    Google Scholar 

  7. Tselis AC, Lisak RP (1995). Acute disseminated encephalomyelitis and isolated central nervous system demyelinative syndromes. Curr Opin Neurol 8(3):227–229. Review.

    PubMed  CAS  Google Scholar 

  8. Zettl UK, Lehmitz R, Mix E (2003). Klinische Liquordiagnostik. De Gruyter Berlin-New York.

    Google Scholar 

Literatur

  1. Ilhan I, Berberoglu S, Kutluay L, Maden HA (1998). Subcutaneous sacrococcygeal myxopapillary ependymoma. Med Pediatr Oncol 30:81–84.

    Article  PubMed  CAS  Google Scholar 

  2. Newton HB, Henson J, Walker RW (1992). Extraneural metastases in ependymoma. J Neuro-Oncol 14:135–142.

    Article  CAS  Google Scholar 

Literatur

  1. Fehlings MG, Rao SC (2000). Spinal Cord and Spinal Column Tumors. In: Bernstein M, Berger MS (eds.) Neuro-Oncology. The Essentials. Thieme, New York 445–464.

    Google Scholar 

  2. Trappe AE, Frank AM, Grosu AL, Hiller E, Jaschke H, Mayer TE, Weinzierl FX (2001). Primäre Tumoren des Rückenmarks. In: Tumorzentrum München (Hrsg.) Hirntumoren und primäre Tumoren des Rückenmarks. Zuckschwerdt, München 147–154.

    Google Scholar 

Literatur

  1. Taylor MD, Rulka JT (2000). Pediatric Posterior Fossa Tumors. In: Bernstein M, Berger MS (eds.) Neuro-Oncology. The Essentials. Thieme, New York 363–376.

    Google Scholar 

  2. Kleihue P, Cavenee WK (2000). Tumors of the Nervous System. WHO Classification of Tumors. IARC Press, Lyon.

    Google Scholar 

  3. Haas RJ, Müller-Weirich S, Poellinger B, Goetz (2001). Pädiatrische ZNS Tumoren. In: Tumorzentrum München (Hrsg.) Hirntumoren und primäre Tumoren des Rückenmarks. Zuckschwerdt, München 76–88.

    Google Scholar 

Literatur

  1. Commission on Classification and Terminology of the International League against Epilepsy (1989). Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30:389–399.

    Google Scholar 

Literatur

  1. Commission on Classification and Terminology of the International League against Epilepsy (1989). Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30:389–399.

    Google Scholar 

Literatur

  1. Commission on Classification and Terminology of the International League against Epilepsy (1989) Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30:389–399.

    Google Scholar 

Literatur

  1. Commission on Classification and Terminology of the International League against Epilepsy (1989) Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30:389–399

    Google Scholar 

Literatur

  1. Commission on Classification and Terminology of the International League against Epilepsy (1989) Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30:389–399.

    Google Scholar 

  2. Kellett MW, Smith DF, Stockton PA, Chadwick DW (1999) Topiramate in clinical practice: first year’s postlicensing experience in a specialist epilepsy clinic. J Neurol Neurosurg Psychiatry 66:759–763.

    Article  PubMed  CAS  Google Scholar 

Literatur

  1. Genton P, Guerrini R, Remy C (1999). Piracetam in the treatment of cortical myoclonus. Pharmacopsychiatry 32Suppl 1:49–53.

    PubMed  CAS  Google Scholar 

  2. Leppik IE (1999). Zonisamide. Epilepsia 40Suppl 5:23–29.

    Google Scholar 

  3. Uldall P, Buchholt JM(1999). Clinical experiences with topiramate in children with intractable epilepsy. Europ J Paediatr Neurol 3:105–111.

    CAS  Google Scholar 

  4. Genton P (2000). Levetiracetam bei myoklonischen Syndromen. Vortrag Deutsch-Österreichisch-Schweizer Arbeitskreis Epilepsie, Sils-Maria, 8.4.2000.

    Google Scholar 

Literatur

  1. Commission on Classification and Terminology of the International League against Epilepsy (1989). Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30:389–399.

    Google Scholar 

Literatur

  1. Pohlmann-Eden B, Hoch DB, Cochius JI, Hennerici MG (1996). Stroke and epilepsy: Part I: Epidemiology and risk factors. Cerbebrovasc Dis 6:332–338.

    Google Scholar 

  2. Pohlmann-Eden B (1999). Schlaganfall-Epilepsie-Syndrome — Eine gesundheitsökonomische und akademische Herausforderung. Epilepsieblätter 12:94–100.

    Google Scholar 

  3. Krakow K, Pohlmann-Eden B (1999). Epilepsien und epileptische Anfälle im höheren Lebensalter. Dtsch Med Wschr 124:567–572.

    PubMed  CAS  Google Scholar 

  4. Lühdorf K, Jensen L, Plesner AM (1986). Epilepsy in the elderly: Incidence, sozial function, and disability. Epilepsia 27:458–463.

    PubMed  Google Scholar 

Literatur

  1. Goldstein D et al. (1998) Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 338:1458–1459.

    Article  Google Scholar 

  2. Vogt HJ et al.(1997) Double-blind, placebocontrolled safety and efficacy trial with yohimbine hydrochlorid in the treatment of nonorganic erectile dysfunction. Int J Impotence Res 9(3):155–161.

    CAS  Google Scholar 

  3. Padma-Nathan et al. (1998) Efficacy and safety of apomorphine SL vs placebo for male erectile dysfunction. J Urol 159:A920.

    Google Scholar 

Literatur

  1. Sha Shapiro ED, Gerber MA, Holabird NB, et al. (1992) A controlled trial of antimicrobial prophylaxis for Lyme disease after deer-tick bites. N Engl J Med 327:1769–73.

    Google Scholar 

  2. Steere AC, Sikand VK, Meurice F, et al. (1998) Vaccination against Lyme disease with recombi-nant Borrelia burgdorferi outer surface protein lipoprotein A with adjuvant. N Engl J Med 339:209–15.

    Article  PubMed  CAS  Google Scholar 

Literatur

  1. Kleihues P, Cavenee WK (2000). Tumors of the Nervous System. WHO Classification of Tumors. IARC Press, Lyon.

    Google Scholar 

  2. Kadish S, Goodman M, Wang CC (1976). Olfactory neuroblastomas. A clinical analysis of 17 cases. Cancer 37:1571–1576.

    PubMed  CAS  Google Scholar 

  3. Schramm J, Kristof RA (1998). Neuronale und neurogliale Tumoren. In: Schlegel U, Westphal M (Hrsg.) Neuroonkologie. Thieme, Stuttgart.

    Google Scholar 

Download references

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

(2005). E. In: Berlit, P. (eds) Therapielexikon Neurologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26367-5_5

Download citation

  • DOI: https://doi.org/10.1007/3-540-26367-5_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-67137-4

  • Online ISBN: 978-3-540-26367-8

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics